28329231|t|Cardiac protective effects of remote ischaemic preconditioning in children undergoing tetralogy of fallot repair surgery: a randomized controlled trial
28329231|a|Remote ischaemic preconditioning (RIPC) by inducing brief ischaemia in distant tissues protects the heart against myocardial ischaemia-reperfusion injury (IRI) in children undergoing open-heart surgery, although its effectiveness in adults with comorbidities is controversial. The effectiveness and mechanism of RIPC with respect to myocardial IRI in children with tetralogy of Fallot (ToF), a severe cyanotic congenital cardiac disease, undergoing open heart surgery are unclear. We hypothesized that RIPC can confer cardioprotection in children undergoing ToF repair surgery. Overall, 112 ToF children undergoing radical open cardiac surgery using cardiopulmonary bypass (CPB) were randomized to either a RIPC group (n = 55) or a control group (n = 57). The RIPC protocol consisted of three cycles of 5-min lower limb occlusion and 5-min reperfusion using a cuff-inflator. Serum inflammatory cytokines and cardiac injury markers were measured before surgery and after CPB. Right ventricle outflow tract (RVOT) tissues were collected during the surgery to assess hypoxia-inducible factor (Hif)-1α and other signalling proteins. Cardiac mitochondrial injury was assessed by electron microscopy. The primary results showed that the length of stay in the intensive care unit (ICU) was longer in the control group than in the RIPC group (52.30 ± 13.43 h vs. 47.55 ± 10.34 h, respectively, P = 0.039). Patients in the control group needed longer post-operative ventilation time compared to the RIPC group (35.02 ± 6.56 h vs. 31.96 ± 6.60 h, respectively, P = 0.016). The levels of post-operative serum troponin-T at 12 and 18 h, CK-MB at 24 h, as well as the serum h-FABP levels at 6 h, after CPB were significantly lower, which was coincident with significantly higher protein expression of cardiac Hif-1α, p-Akt, p-STAT3, p-STAT5, and p-eNOS and less vacuolization of mitochondria in the RIPC group compared to the control group. In ToF children undergoing open heart surgery, RIPC attenuates myocardial IRI and improves the short-term prognosis.
28329231	0	7	Cardiac	T017	UMLS:C0018787
28329231	30	62	remote ischaemic preconditioning	T058	UMLS:C0376466
28329231	86	120	tetralogy of fallot repair surgery	T058	UMLS:C0397326
28329231	124	151	randomized controlled trial	T062	UMLS:C0206035
28329231	152	184	Remote ischaemic preconditioning	T058	UMLS:C0376466
28329231	186	190	RIPC	T058	UMLS:C0376466
28329231	210	219	ischaemia	T038	UMLS:C0022116
28329231	223	230	distant	T082	UMLS:C0443203
28329231	231	238	tissues	T017	UMLS:C0040300
28329231	252	257	heart	T017	UMLS:C0018787
28329231	266	276	myocardial	T017	UMLS:C0027061
28329231	277	305	ischaemia-reperfusion injury	T037	UMLS:C0035126
28329231	307	310	IRI	T037	UMLS:C0035126
28329231	335	353	open-heart surgery	T058	UMLS:C0189745
28329231	464	468	RIPC	T058	UMLS:C0376466
28329231	485	495	myocardial	T017	UMLS:C0027061
28329231	496	499	IRI	T037	UMLS:C0035126
28329231	517	536	tetralogy of Fallot	T017	UMLS:C0039685
28329231	538	541	ToF	T017	UMLS:C0039685
28329231	573	588	cardiac disease	T038	UMLS:C0018799
28329231	601	619	open heart surgery	T058	UMLS:C0189745
28329231	654	658	RIPC	T058	UMLS:C0376466
28329231	710	728	ToF repair surgery	T058	UMLS:C0397326
28329231	743	746	ToF	T017	UMLS:C0039685
28329231	775	795	open cardiac surgery	T058	UMLS:C0189745
28329231	802	824	cardiopulmonary bypass	T058	UMLS:C0007202
28329231	826	829	CPB	T058	UMLS:C0007202
28329231	859	863	RIPC	T058	UMLS:C0376466
28329231	912	916	RIPC	T058	UMLS:C0376466
28329231	917	925	protocol	T058	UMLS:C0040808
28329231	961	981	lower limb occlusion	T058	UMLS:C0190956
28329231	992	1003	reperfusion	T058	UMLS:C0027054
28329231	1012	1025	cuff-inflator	T074	UMLS:C3881496
28329231	1027	1032	Serum	T031	UMLS:C0229671
28329231	1046	1055	cytokines	T103	UMLS:C0079189
28329231	1060	1074	cardiac injury	T037	UMLS:C0018805
28329231	1075	1082	markers	T201	UMLS:C0005516
28329231	1104	1111	surgery	T058	UMLS:C0543467
28329231	1122	1125	CPB	T058	UMLS:C0007202
28329231	1127	1156	Right ventricle outflow tract	T082	UMLS:C0225892
28329231	1158	1162	RVOT	T082	UMLS:C0225892
28329231	1164	1171	tissues	T017	UMLS:C0040300
28329231	1198	1205	surgery	T058	UMLS:C0543467
28329231	1216	1249	hypoxia-inducible factor (Hif)-1α	T103	UMLS:C0965644
28329231	1260	1270	signalling	T038	UMLS:C3537152
28329231	1271	1279	proteins	T103	UMLS:C0033684
28329231	1281	1288	Cardiac	T017	UMLS:C0018787
28329231	1289	1302	mitochondrial	T017	UMLS:C0026237
28329231	1326	1345	electron microscopy	T058	UMLS:C0026019
28329231	1405	1424	intensive care unit	T092	UMLS:C0021708
28329231	1426	1429	ICU	T092	UMLS:C0021708
28329231	1475	1479	RIPC	T058	UMLS:C0376466
28329231	1609	1625	ventilation time	T033	UMLS:C0456238
28329231	1642	1646	RIPC	T058	UMLS:C0376466
28329231	1744	1760	serum troponin-T	T033	UMLS:C1318385
28329231	1777	1782	CK-MB	T058	UMLS:C0523584
28329231	1841	1844	CPB	T058	UMLS:C0007202
28329231	1918	1936	protein expression	T038	UMLS:C1171362
28329231	1948	1954	Hif-1α	T103	UMLS:C0965644
28329231	1963	1970	p-STAT3	T103	UMLS:C1530116
28329231	1972	1979	p-STAT5	T103	UMLS:C1121634
28329231	1985	1991	p-eNOS	T103	UMLS:C0669365
28329231	2001	2014	vacuolization	T033	UMLS:C0010840
28329231	2018	2030	mitochondria	T017	UMLS:C0026237
28329231	2038	2042	RIPC	T058	UMLS:C0376466
28329231	2083	2086	ToF	T017	UMLS:C0039685
28329231	2107	2125	open heart surgery	T058	UMLS:C0189745
28329231	2127	2131	RIPC	T058	UMLS:C0376466
28329231	2143	2153	myocardial	T017	UMLS:C0027061
28329231	2154	2157	IRI	T037	UMLS:C0035126
28329231	2162	2170	improves	T033	UMLS:C0184511
28329231	2186	2195	prognosis	T201	UMLS:C3854082